Marksans Pharma Ltd.
|
Balance Sheet
|
|
You can view the
Balance Sheet
for the last 5 years.
Market Cap. (Rs.)
|
7640.34 Cr.
|
P/BV
|
3.35
|
Book Value (Rs.)
|
50.34
|
52 Week High/Low (Rs.)
|
359/169
|
FV/ML
|
1/1
|
P/E(X)
|
20.08
|
Bookclosure
|
01/08/2025
|
EPS (Rs.)
|
8.40
|
Div Yield (%)
|
0.47
|
|
(Rs. in Crs.)
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
No. of Equity Shares (in Lacs) | 4531.64 | 4531.64 | 4531.64 | 4093.14 | 4093.14 |
| | | | | |
EQUITIES AND LIABILITIES | | | | | |
SHAREHOLDER'S FUNDS | | | | | |
Equity Share Capital | 45.32 | 45.32 | 45.32 | 40.93 | 40.93 |
Total Share Capital | 45.32 | 45.32 | 45.32 | 40.93 | 40.93 |
| | | | | |
Reserves and Surplus | 2421.60 | 2019.74 | 1699.85 | 1161.34 | 845.56 |
Total Reserves and Surplus | 2421.60 | 2019.74 | 1699.85 | 1161.34 | 845.56 |
Total Shareholders Funds | 2466.91 | 2065.05 | 1745.16 | 1202.27 | 886.49 |
Minority Interest | 22.47 | 20.85 | 19.91 | 20.70 | 18.86 |
| | | | | |
NON-CURRENT LIABILITIES | | | | | |
Deferred Tax Liabilities [Net] | 3.66 | 10.62 | 15.39 | 17.62 | 8.06 |
Other Long Term Liabilities | 269.25 | 190.02 | 65.69 | 41.43 | 14.33 |
Long Term Provisions | 0.00 | 4.56 | 3.25 | 1.86 | 2.11 |
Total Non-Current Liabilities | 272.91 | 205.20 | 84.33 | 60.91 | 24.50 |
| | | | | |
CURRENT LIABILITIES | | | | | |
Short Term Borrowings | 23.09 | 29.09 | 41.59 | 41.29 | 18.74 |
Trade Payables | 305.70 | 268.28 | 230.60 | 200.08 | 168.66 |
Other Current Liabilities | 148.56 | 90.53 | 67.48 | 114.12 | 109.14 |
Short Term Provisions | 0.00 | 1.96 | 1.33 | 0.72 | 1.85 |
Total Current Liabilities | 477.34 | 389.85 | 340.99 | 356.22 | 298.40 |
| | | | | |
Total Capital And Liabilities | 3239.63 | 2680.95 | 2190.39 | 1640.10 | 1228.25 |
| | | | | |
ASSETS | | | | | |
NON-CURRENT ASSETS | | | | | |
Tangible Assets | 886.41 | 675.71 | 379.64 | 341.59 | 248.42 |
Intangible Assets | 54.62 | 60.73 | 68.17 | 56.69 | 60.94 |
Capital Work-In-Progress | 9.00 | 5.38 | 7.25 | 0.70 | 5.60 |
Intangible Assets Under Development | 18.11 | 4.04 | 2.62 | 1.88 | 6.08 |
Fixed Assets | 968.14 | 745.85 | 457.69 | 400.86 | 321.04 |
Goodwill On Consolidation | 40.93 | 39.50 | 38.49 | 30.03 | 0.00 |
Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 3.86 | 0.80 |
Other Non-Current Assets | 26.44 | 33.11 | 18.91 | 4.16 | 4.16 |
Total Non-Current Assets | 1035.51 | 818.46 | 515.09 | 438.90 | 326.00 |
| | | | | |
| | | | | |
CURRENT ASSETS | | | | | |
Current Investments | 0.74 | 26.99 | 0.54 | 0.44 | 0.00 |
Inventories | 845.52 | 617.94 | 484.74 | 424.44 | 404.32 |
Trade Receivables | 540.04 | 453.18 | 416.85 | 394.78 | 271.38 |
Cash And Cash Equivalents | 704.21 | 673.58 | 714.96 | 349.27 | 212.29 |
OtherCurrentAssets | 113.61 | 90.80 | 58.21 | 32.28 | 14.26 |
Total Current Assets | 2204.12 | 1862.49 | 1675.30 | 1201.20 | 902.25 |
| | | | | |
Total Assets | 3239.63 | 2680.95 | 2190.39 | 1640.10 | 1228.25 |
| | | | | |
OTHER INFORMATION | | | | | |
| | | | | |
CONTINGENT LIABILITIES, COMMITMENTS | | | | | |
Contingent Liabilities | 34.15 | 45.87 | 9.31 | 17.02 | 19.78 |
| | | | | |
CURRENT INVESTMENTS | | | | | |
Current Investments Unquoted Book Value | 0.74 | 26.99 | 0.00 | 0.00 | 0.00 |